Other well-known risk factors, such as diabetes, obesity, dyslipidemia and older age, showed a trend that did not reach the pre-defined statistical threshold.
← all excerpts
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib.
1
—
—